 |
 |

Transmissible Spongiform Encephalopathies and the US Blood Supply
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: I am writing to express the concern of the American Association of Blood Banks (AABB) about a Medical News & Perspectives article regarding transmissible spongiform encephalopathies (TSEs) and the US blood supply.1 Unsubstantiated statements such as " . . . guardians of the blood supply were slow to react . . . ," " . . . public health leaders are flying blind on TSEs . . . ," and " . . . do-nothing policies that could someday see thousands facing horrific deaths from these mysterious diseases" are, in our opinion, both speculative and sensational. We believe these statements damage the hard work of the AABB and the entire medical community in ensuring the safety of the blood supply and patient care in general.
Moreover, the article contains several factual inaccuracies. First, the statement that there is a "current FDA [Food and Drug Administration] policy of . . . [Full Text of this Article]
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Capturing the Patient's View of Change as a Clinical Outcome Measure
David Fischer, Anita L. Stewart, Daniel A. Bloch, Kate Lorig, Diana Laurent, and Halsted Holman
JAMA. 1999;282(12):1157-1162.
ABSTRACT
| FULL TEXT
|